Artificial intelligence startups continued their dominance of venture capital activity this week, capturing the bulk of the largest U.S. funding rounds announced. The concentration of mega-deals in the AI sector reflects the market's sustained conviction that AI technology represents the most promising near-term investment opportunity across the startup landscape. Only biotech emerged as a meaningful secondary focus for capital, demonstrating how thoroughly AI has consolidated investor attention and funding resources in the current market cycle.
The funding momentum comes amid a complex backdrop. While over 127,000 tech workers faced layoffs in 2025 with cuts continuing into 2026, capital allocation to AI startups has remained largely insulated from broader economic headwinds. This divergence highlights how investors are actively rotating capital away from struggling segments toward perceived winners, with AI receiving disproportionate share of available venture funds despite macroeconomic uncertainty and workforce reductions across the industry.
XCures' $46 million Series B, led by Innovius Capital, exemplifies the trend: an AI-powered medical records platform attracting substantial growth-stage investment. Meanwhile, larger M&A activity—including SpaceX's $60 billion acquisition of Anysphere—signals that AI talent and technology remain acquisition targets for major players. Together, these patterns indicate the venture ecosystem is decisively betting on AI's profitability and market potential, even as questions persist about funding diversity and access for non-AI-focused founders seeking capital in an increasingly concentrated landscape.